Effect of lipoxygenase inhibition on mucous glycoprotein secretion from chinchilla middle ear epithelial cells in vitro.
Lipoxygenase is an enzyme that metabolizes arachidonic acid down to leukotrienes. Recent studies have shown that the enzyme is implicated in mucous glycoprotein (MGP) secretion stimulated by inflammatory mediators in the airways, suggesting its possible role in secretion of MGP from middle ear epithelial cells. To investigate a correlation between MGP secretion and the arachidonic acid metabolites, we examined the effects of nordihydroguaretic acid (NDGA, both a cyclooxygenase and lipoxygenase inhibitor), low-dose indomethacin (an inhibitor of cyclooxygenase), and A63162 (an inhibitor of lipoxygenase) on MGP secretion in cultured chinchilla middle ear epithelial cells. It was found that lipoxygenase inhibition led to reduction of MGP secretion from cultured chinchilla middle ear epithelial cells, while cyclooxygenase inhibition did not. Both cyclooxygenase and lipoxygenase inhibition resulted in profound blockage of MGP secretion in baseline and platelet activating factor-stimulated MGP secretion. It was concluded, therefore, that MGP secretion was linked to arachidonic acid metabolites, especially lipoxygenase products.
Otitis Media Research Center, Department of Otolaryngology, University of Minnesota School of Medicine, Minneapolis, USA.
J
J
Lin
Y
Y
Kim
C
C
Less
F
F
Ondrey
S K
SK
Juhn
D000081:Acetamides / Q000494:pharmacology*; D000818:Animals; D016718:Arachidonic Acid / Q000502:physiology; D002478:Cells, Cultured; D002682:Chinchilla; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004432:Ear, Middle / Q000187:drug effects / Q000378:metabolism*; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology*; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology*; D009637:Masoprocol / Q000494:pharmacology*; D010647:Phenyl Ethers; D010972:Platelet Activating Factor / Q000494:pharmacology
D000081:Acetamides; D016861:Cyclooxygenase Inhibitors; D006023:Glycoproteins; D016859:Lipoxygenase Inhibitors; D010647:Phenyl Ethers; D010972:Platelet Activating Factor; C047874:gastric mucus glycoproteins; C068663:N-hydroxy-N-(1-(4-(phenylmethoxy)phenyl)ethyl)-acetamide; D016718:Arachidonic Acid; D009637:Masoprocol; D007213:Indomethacin